Skip to main content

Diet Therapy in the Context of Chronic Pelvic Pain

  • Chapter
  • First Online:
  • 986 Accesses

Abstract

The synergistic relationship between food and well-being is beyond doubt. With the discovery that vitamins and minerals eradicate deficiency diseases, the role of these essential nutrients in maintaining health and mitigating disease has been confirmed for centuries. Indeed, there is now abundant evidence that comestibles enhance health through complex biological mechanisms [14].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Arjmandi BH, Khalil DA, Lucas EA, Smith BJ, Sinichi N, Hodges SB, et al. Soy protein may alleviate osteoarthritis symptoms. Phytomedicine. 2004;11(7-8):567–75.

    Article  CAS  PubMed  Google Scholar 

  2. Esposito K, Nappo F, Giugliano F, Giugliano G, Marfella R, Giugliano D. Effect of dietary antioxidants on postprandial endothelial dysfunction induced by a high-fat meal in healthy subjects. Am J Clin Nutr. 2003;77(1):139–43.

    CAS  PubMed  Google Scholar 

  3. Maroon JC, Bost JW. Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain. Surg Neurol. 2006;65(4):326–31.

    Article  PubMed  Google Scholar 

  4. Tall JM, Srinivasa N. Dietary constituents as novel therapies for pain. Clin J Pain. 2004;20(1):19–26.

    Article  PubMed  Google Scholar 

  5. Jakobsen MU, O’Reily EJ, Heitmann BL, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89(5):1425–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003;78(12):1463–70.

    Article  PubMed  Google Scholar 

  7. Richman EL, Sttampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM. Intakes of meat, fish, poultry and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010;91(3):712–21.

    Article  CAS  PubMed  Google Scholar 

  8. Gul Z, Monga M. Medical and dietary therapy for kidney stone prevention. Korean J Urol. 2014;55(12):775–9.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Sonn GA, Aronson W, Litwin MS. Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis. 2005;8(4):304–10.

    Article  CAS  PubMed  Google Scholar 

  10. Bassaly R, Downes K, Hart S. Dietary consumption triggers in interstitial cystitis/bladder pain syndrome patients. Female Pelvic Med Reconstr Surg. 2011;17(1):36–9.

    Article  PubMed  Google Scholar 

  11. Bassaly R, Tidwell N, Bertolino S, et al. Myofascial pain and pelvic floor dysfunction in patients with interstitial cystitis. Int Urogynecol J. 2011;22(4):413–8.

    Article  PubMed  Google Scholar 

  12. Gallo L. Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer and Prostatic Dis. 2014;17:238–45.

    Article  CAS  Google Scholar 

  13. Heizer WD, Southern S, McGovern S. The role of diet in symptoms of irritable bowel syndrome in adults: a narrative review. J Am Diet Assoc. 2009;109(7):1204–14.

    Article  PubMed  Google Scholar 

  14. Holton KF, Kindler LL, Jones KD. Potential dietary links to central sensitization in fibromyalgia: past reports and future directions. Rheum Dis Clin N Am. 2009;35(2):409–20.

    Article  Google Scholar 

  15. Shorter B, Lesser M, Moldwin RM, Kushchner L. Effect of comestibles on symptoms of interstitial cystitis. J Urol. 2007;178(1):145–52.

    Article  PubMed  Google Scholar 

  16. Friedlander JI, Shorter B, Moldwin RM. Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions. BJU Int. 2012;109(11):1584–91.

    Article  PubMed  Google Scholar 

  17. Gillespie L. Metabolic appraisal of the effects of dietary modification on hypersensitive bladder symptoms. Br J Urol. 1993;72(3):293–7.

    Article  CAS  PubMed  Google Scholar 

  18. Gillespie L, Blakeslee S. You don’t have to live with cystitis! New York: Rawson Associates; 1986.

    Google Scholar 

  19. Koziol JA, Douglas CC, Gittes RF, Tan EM. The natural history of interstitial cystitis: a survey of 374 patients. J Urol. 1993;149(3):465–9.

    CAS  PubMed  Google Scholar 

  20. O’Hare 3rd PG, Hoffmann AR, Allen P, Gordon B, Salin L, Whitmore K. Interstitial cystitis patients’ use and rating of complementary and alternative medicine therapies. Int Urogynecol J. 2013;24(6):977–82.

    Article  PubMed  Google Scholar 

  21. Rovner E, Propert KJ, Brensinger C, Wein AJ, Foy M, Kirkemo A. Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group. Urol. 2000;56(6):940–5.

    Article  CAS  PubMed  Google Scholar 

  22. Warren JW, Brown J, Tracy JK, et al. Evidence-based criteria for the pain of interstitial cystitis/painful bladder syndrome in women. Urology. 2008;71(3):444–8.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Whitmore KE. Self-care regiments for patients with interstitial cystitis. Urol Clin North Am. 1994;21(1):121–30.

    CAS  PubMed  Google Scholar 

  24. Sutcliffe S, Bradley CS, Clemens JQ. Urological chronic pelvic pain syndrome flares and their impact: qualitative analysis in the MAPP network. Int Urogynecol J. 2015;26:1047–60.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Solomons CC, Melmed MH, Heitler SM. Calcium citrate for vulvar vestibulitis. A case report. J Reprod Med. 1991;36(12):879–82.

    CAS  PubMed  Google Scholar 

  26. Clinical management of vulvodynia. Gynaecological Practice. 2002;2(1-2). www.obgyn.net/pelvic-pain/clinical-management-vulvodynia. Accessed 9 Sep 2015.

  27. Harlow BL, Abenhaim HA, Vitonis AF, Harnack L. Influence of dietary oxalates on the risk of adult-onset vulvodynia. J Reprod Med. 2008;53(3):171–8.

    PubMed  Google Scholar 

  28. Baggish MS, Sze EH, Johnson R. Urinary oxalate excretion and its role in vulvar pain syndrome. Am J Obstet Gynecol. 1997;177(3):507–11.

    Article  CAS  PubMed  Google Scholar 

  29. Munday P, Buchan A, Ravenhill G, Wiggs A, Brooks F. A qualitative study of women with vulvodynia: II. Response to a multidisciplinary approach to management. J Repro Med. 2007;52(1):19–22.

    Google Scholar 

  30. Poole S, Ravenhill G, Munday PE. A pilot study of the use of a low oxalate diet in the treatment of vulval vestibulitis. J Obstet Gynaecol. 1999;19(3):271–2.

    Article  CAS  PubMed  Google Scholar 

  31. Herati AS, Shorter B, Srinivasan AK, Tai J, Seideman C, Lesser M, et al. Effects of foods and beverages on the symptoms of chronic prostatitis/chronic pelvic pain syndrome. Urology. 2013;82(6):1376–80.

    Article  PubMed  Google Scholar 

  32. Bartoletti R, Cai T, Mondaini N, Dinelli N, Pinzi N, Pavone C, Italian Prostatitis Study Group, et al. Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study. J Urol. 2007;178(6):2411–5.

    Article  PubMed  Google Scholar 

  33. Collins MM, Meigs JB, Barry MJ, Walker Corkery E, Giovannucci E, Kawachi I. Prevalence and correlates of prostatitis in health professionals follow-up study cohort. J Urol. 2002;167(3):1363–6.

    Article  PubMed  Google Scholar 

  34. Liang CZ, Li HJ, Wang ZP, Xing JP, Hu WL, Zhang TF, et al. The prevalence of prostatitis-like symptoms in China. J Urol. 2009;182(2):558–63.

    Article  PubMed  Google Scholar 

  35. Link CL, Pulliam SJ, Hanno PM, Hall SA, Eggers PW, Kusek JW, et al. Prevalence and psychosocial correlates of symptoms suggestive of painful bladder syndrome: results from Boston area community health survey. J Urol. 2008;180(2):599–606.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Shoskes D. The status quo is not good enough (but it can be). Commentary on Chronic Prostatitis/Chronic Pelvic Pain Syndrome 2010;3(3). www.urotodayinternationanljournal.com. Accessed 11 Jun 2015.

  37. ACOG Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 51. Chronic pelvic pain. Obstet Gynecol. 2004;103(3):589–605.

    Article  Google Scholar 

  38. ACOG Committee Opinion No. 345: Vulvodynia. American College of obstetricians and gynecologists. Obstet Gynecol. 2006;108:1049–52.

    Article  Google Scholar 

  39. Estaban M, Adot JM, Arlandis S. Working group for recommendations of the diagnosis and management of bladder pain syndrome. Recommendations for the diagnosis and management of bladder pain syndrome: Spanish urological association consensus document. Actas Urol Exp. 2015;39(8):465–72. doi:10.1016/j.acuro.2015.01.006.

    Article  Google Scholar 

  40. Haefner HK, Collins ME, Davis GD, Edwards L, Foster DC, Hartmann ED, et al. The vulvodynia guideline. J Lower Genital Tract Dis. 2005;9(1):40–51.

    Article  Google Scholar 

  41. Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–70.

    Article  PubMed  Google Scholar 

  42. Homma Y, Ueda T, Ito T, Takei M, Tomoe H. Japanese Guideline for diagnosis and treatment of interstitial cystitis. Int J Urol. 2009;16(1):4–16.

    Article  PubMed  Google Scholar 

  43. Homma Y, Ueda T, Tomoe H, Interstitial cystitis guideline committee. Japanese urological association. Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Int J Urol. 2009;16(7):597–615.

    Article  PubMed  Google Scholar 

  44. Mandal D, Nunns D, Byrne M, McLelland J, Rani R, Cullimore J, et al. Guidelines for the management of vulvodynia. Br J Derm. 2010;162(6):1180–5.

    Article  Google Scholar 

  45. Nickel JC. Prostatitis. Canadian Urol Assn J. 2011;5(5):306–15.

    Article  Google Scholar 

  46. Royal College of Obstetricians and Gynaecologists. Green-top Guideline No. 41: Initial management of chronic pelvic pain. 2012. www.rcog.org.uk/globalassets/documents/guidelines/gtg_41.pdf. Accessed 15 Jun 2015.

  47. Engeler D, Baranowski AP, Dinid-Oliveira P, Elneil S, Hughes J, Messelink EJ, et al. The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol. 2013;64(3):431–9.

    Article  PubMed  Google Scholar 

  48. Hanno PM, Burks DA, Clemins JQ, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. 2015; Accessed online www.auanet.org/education/ic-bladder-pain-syndrome.cfm.

  49. Nazif O, Teichman JM, Gebhart GF. Neural upregulation in interstitial cystitis. Urol. 2007;69(4 Suppl):24–33.

    Article  PubMed  Google Scholar 

  50. Parsons CL. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology. 2007;69(4 Suppl):9–16.

    Article  PubMed  Google Scholar 

  51. Rudnick CN, Chen MC, Monglu AK, Klumpp DJ. Organ cross talk modulates pelvic pain. Am J Physiol Regul Integr Comp Physiol. 2007;293(3):R1191–8.

    Article  CAS  Google Scholar 

  52. Ustihova EE, Fraser MO, Pessone MA. Cross-talk and sensitization of bladder afferent nerves. Neurourol Urodyn. 2010;29(1):77–81.

    Article  Google Scholar 

  53. Wesselmann U. Neurogenic inflammation and chronic pelvic pain. World J Urol. 2001;19(3):180–5.

    Article  CAS  PubMed  Google Scholar 

  54. Hauser PJ, Dozmorov MG, Bane BL, Slobodov G, Culkin DJ, Hurst RE. Abnormal expression of differentiation related proteins in the urothelium of interstitial cystitis patients. J Urol. 2008;179(2):764–9.

    Article  CAS  PubMed  Google Scholar 

  55. Hurst RE, Moldwin RM, Mulholland SG. Bladder defense molecules, urothelial differentitation, urinary biomarkers, and interstitial cysititis. Urol. 2007;69(4 Suppl):17–23.

    Article  PubMed  Google Scholar 

  56. Mukerji G, Yiangou Y, Agarwal SK, Anand P. Transient receptor potential subtype 1 in painful bladder syndrome and its correlation with pain. J Urol. 2006;176(2):797–801.

    Article  CAS  PubMed  Google Scholar 

  57. Faubion SS, Shuster LT, Bharucha AE. Recognition and management of nonrelaxing pelvic floor dysfunction. Mayo Clin Proc. 2012;87(2):187–93.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Pastore EA, Katzman WB. Recognizing myofascial pelvic pain in the female patient with chronic pelvic pain. J Obstet Gynecol Neonatal Nurs. 2012;41(5):680–91.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Sarton J. Physical therapy for pelvic pain: understanding the musculoskeletal connection. The Female Patient. 2007;32:50–6.

    Google Scholar 

  60. Kaplan SA, Dmochowski R, Cash BD, Kopp ZS, Berriman SJ, Khullar V. Systematic review of the relationship between bladder and bowel function: implications for patient management. Int J Clin Pract. 2013;67:205–16.

    Article  CAS  PubMed  Google Scholar 

  61. Andrews JC. Vulvodynia: an evidence-based approach to medical management. JCOM. 2010;17(5):225–38.

    Google Scholar 

  62. Butrick CW. Pathophysiology of pelvic floor hypertonic disorders. Obstet Gynecol Clin North Am. 2009;36(3):699–705. doi:10.1016/j.ogc.2009.08.006.

    Article  PubMed  Google Scholar 

  63. Hartmann D, Sarton J. Chronic pelvic floor dysfunction. Best Pract Res Clin Obstet Gynaecol. 2014;28(7):977–90.

    Article  PubMed  Google Scholar 

  64. McBeth J, Pye SR, O’Neill TW, Macfarlane GJ, Tajar A, Bartfai G, EMAS Group, et al. Musculoskeletal pain is associated with very low levels of vitamin D in men: results from the European Male Ageing Study. Ann Rheum Dis. 2010;69(8):1448–52.

    Article  PubMed  Google Scholar 

  65. Straube S, Derry S, Morre RA, McQuay HJ. Vitamin D for the treatment of chronic conditions in adults. Conchrone Datbase Syst Rev. 2010;1:CD007771.

    Google Scholar 

  66. Badalian SS, Rosenbaum PF. Vitamin D and pelvic floor disorders in women: results from the National Health and Nutrition Examination Survey. Obstet Gynecol. 2010;115(4):795–803.

    Article  CAS  PubMed  Google Scholar 

  67. Parker-Autry CY, Markland AD, Ballard AC, Downs-Gunn D, Richter H. Vitamin D status in women with pelvic floor disorder symptoms. Int Urogynecol J. 2012;23(12):1699–705.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Parker-Autry CY, Burgio KL, Richter HE. Vitamin D Status—A clinical review with implications for the pelvic floor. Int Urogynecol J. 2012;23(11):1517–26.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Reed BD. Vulvodynia: diagnosis and management. Am Fam Physician. 2006;73(7):1231–8.

    PubMed  Google Scholar 

  70. Robinson D, Giarenis I, Cardozo L. You are what you eat: the impact of diet on overactive bladder and lower urinary tract symptoms. Maturitas. 2014;79:8–13.

    Article  CAS  PubMed  Google Scholar 

  71. Shorter B, Ackerman M, Varvara M, Moldwin RM. Statistical validation of the shorter-moldwin food sensitivity questionnaire for patients with interstitial cystitis/bladder pain syndrome. J Urol. 2014;191(6):1793–801.

    Article  PubMed  Google Scholar 

  72. Sutcliffe S, Colditz GA, Goodman MS, Pakpahan R, Vetter J, Ness TJ, et al. Urological chronic pelvic pain syndrome symptom flares: characterisation of the full range of flares at two sites in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network. BJU Int. 2014;114(6):916–25.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Gordon B, Shorter S, Sarcona S, Moldwin R. Nutritional considerations for interstitial cystitis/bladder pain syndrome. J Acad Nutr Diet. 2015;115(9):1372–9.

    Article  PubMed  Google Scholar 

  74. Shorter B, Elsamra S, Smith A, Okeke Z. What is a low oxalate diet? NYSDA Annual Meeting, May 2013 Abstract Poster Session.

    Google Scholar 

  75. Massey LK. Food oxalate: factors affecting measurement, biological variation, and bioavailability. J Am Diet Assoc. 2007;107(7):1191–4.

    Article  PubMed  Google Scholar 

  76. Cheungpasitporn W, Rossetti S, Frienhd K, Erickson S, Lieske J. Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis. J Nephrol. 2016;29(2):211–9.

    Article  PubMed  Google Scholar 

  77. National Institutes of Health. Diet for Kidney Stone Prevention. Accessed online www.kidney.niddk.nih.gov NIH Publication No. 13–6425; 2013.

  78. DiNoia J, Prochaska JO. Dietary stages of change and decisional balance: a met-analytic review. Am J Health Behav. 2010;34(5):618–32.

    Google Scholar 

  79. Carrico DJ, Sherer KL, Peters KM. The relationship of interstitial cystitis/painful bladder syndrome to vulvodynia. Urol Nurs. 2009;29(2):233–8.

    PubMed  Google Scholar 

  80. Dell JR, Mokrzycki ML, Jayne CJ. Differentiating interstitial cystitis from similar conditions commonly seen in gynecologic practice. Eur J Obstet Gynecol Reprod Biol. 2009;144(2):105–9.

    Article  PubMed  Google Scholar 

  81. Moldwin R. The interstitial cystitis survival guide. Oakland: New Harbinger; 2000.

    Google Scholar 

  82. Nickel JC, Tripp DA, Pontari M, Moldwin R, Mayer R, Carr LK, et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol. 2010;184(4):1358–63.

    Article  PubMed  Google Scholar 

  83. Parsons CL. Prostatitis, interstitial cystitis, chronic pelvic pain, and urethral syndrome share a common pathophysiology: lower urinary dysfunctional epithelium and potassium recycling. Urology. 2003;62(6):976–82.

    Article  PubMed  Google Scholar 

  84. Peters KM, Carrico DJ, Kalinowski SE, Ibrahim IA, Diokno AC. Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urol. 2007;70(1):16–8.

    Article  PubMed  Google Scholar 

  85. Clemens JQ, Brown SO, Kozloff L, Calhoun EA. Predictors of symptom severity in patients with chronic prostatitis and interstitial cystitis. J Urol. 2006;175(3 Pt 1):963–6. discussion 967.

    Article  PubMed  Google Scholar 

  86. Glazer HI, Ledger WJ. Clinical Management of Vulvodynia. Rev Gynaecol Pract. 2002;2(1-2):83–90.

    Article  Google Scholar 

  87. Allen-Brady K, Norton PA, Cannon-Albright L. Risk of associated conditions in relatives of subjects with interstitial cystitis. Female Pelvic Med Reconstr Surg. 2015;21(2):93–8.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Bezerra LRPS, Neto JAV, Vasconcelos CT, Karbage SA, Lima AC, Frota IP, et al. Prevalence of unreported bowel symptoms in women with pelvic floor dysfunction and the impact on their quality of life. Int Urogynecol J. 2014;25(7):927–33.

    PubMed  Google Scholar 

  89. Berghmans B, Nieman F, Leue C, Weemhoff M, Breukink S, Van Koeveringe G, et al. Prevalence and triage of first contact pelvic floor dysfunction complaints in male patients referred to a Pelvic Care Centre. Neurourol Urodyn. 2016;35(4):487–91. doi:10.1002/nau.22733.

    Article  PubMed  Google Scholar 

  90. Leung L, Riutta T, Kotecha J, Rosser W. Chronic constipation: an evidence-based review. J Am Board Fam Med. 2011;24(4):436–51.

    Article  PubMed  Google Scholar 

  91. Leung FW. Etiologic factors of chronic constipation: review of the scientific evidence [review]. Dig Dis Sci. 2007;52(2):313–6.

    Article  PubMed  Google Scholar 

  92. Müller-Lissner S, Kamm M, Scarpignato C, Wald A. Myths and misconceptions about chronic constipation. Am J Gastroenterol. 2005;100:232–42.

    Article  PubMed  Google Scholar 

  93. Ternent CA, Bastawrous AL, Morin NA, Ellis CN, Hyman NH, Buie WD. Standards practice task force of the American Society of colon and rectal surgeons. practice parameters for the evaluation and management of constipation. Dis Colon Rec. 2007;50(12):2013–22.

    Article  Google Scholar 

  94. Morlion B, Clemens KE, Dunlop W. Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodeone/naloxone. Clin Drug Investig. 2015;35:1–11.

    Article  CAS  PubMed  Google Scholar 

  95. Academy of Nutrition and Dietetics. Nutrition Care Manual®. Academy of Nutrition and Dietetics website. 2014. https://www.nutritioncaremanual.org. Accessed 31 March 2014.

  96. Marlett JA, Cheung TF. Database and quick methods of assessing typical dietary fiber intakes using data for 228 commonly consumed foods. J Am Diet Assoc. 1997;97(10):1139–51.

    Article  CAS  PubMed  Google Scholar 

  97. Palla AH, Gilani AH. Dual effectiveness of flaxseed in constipation and diarrhea: possible mechanism. J Ethnopharm. 2015;169:60–8.

    Article  CAS  Google Scholar 

  98. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC, et al. Function bowel disorders. Gastroenterology. 2006;130(5):1480–91.

    Article  PubMed  Google Scholar 

  99. Kumar L, Barker C, Emmanuel A. Opioid-induced constipation: pathology, clinical consequences, and management. Gastroenterol Res Pract. 2014;2014:1–6. 141737.

    Article  Google Scholar 

  100. Tabi A, Comelli EM. Practical approaches to probiotics use. Appl Physiol Nutr Meta. 2014;39(8):980–6.

    Article  Google Scholar 

  101. Christianson JA, Liang R, Ustinova EE, Davis BM, Fraser MO, Pezzone MA. Convergence of bladder and colon sensory innervation occurs at the primary afferent level. Pain. 2007;128(3):235.

    Article  PubMed  Google Scholar 

  102. Mahan LK, Escott-Stump S. Krause’s food, nutrition, & diet therapy. 12th ed. Philadelphia: Saunders; 2009.

    Google Scholar 

  103. Bode C, Bode JC. Alcohol’s role in gastrointestinal tract disorders. Alcohol Health Res World. 1997;21(1):76–84.

    CAS  PubMed  Google Scholar 

  104. Acheson KJ, Zahorska-Markiewicz B, Pittet P, Anantharaman K, Jéquier E. Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr. 1980;33(5):989–97.

    CAS  PubMed  Google Scholar 

  105. Böhn L, Störsrud S, Törnblom H, Bengtsson U, Simrén M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 2013;108(5):634–41.

    Article  PubMed  CAS  Google Scholar 

  106. Barrett JS, Irving PM, Shepherd SJ, Muir JG, Gibson PR. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther. 2009;30(2):165–74. doi:10.1111/j.1365-2036.2009.04018.x.

    Article  CAS  PubMed  Google Scholar 

  107. Biesiekierski J, Newnham E, Irving P, Barrett JS, Haines M, Doecke JD, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol. 2011;106(3):508–14. doi:10.1038/ajg.2010.487.

    Article  CAS  PubMed  Google Scholar 

  108. Goldstein R, Braverman D, Stankiewicz H. Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints. Isr Med Assoc J. 2000;2(8):583–7.

    CAS  PubMed  Google Scholar 

  109. Melchior C, Gourcerol G, Déchelotte P, Leroi AM, Ducrotté P. Symptomatic fructose malabsorption in irritable bowel syndrome: a prospective study. United European Gastroenterol J. 2014;2(2):131–7.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Vazquez-Roque M, Camilleri M, Smyrk T, et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology. 2013;144(5):903–11. doi:10.1053/j.gastro.2013.01.049.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Choi YK, Kraft N, Zimmerman B, Jackson M, Rao SS. Fructose intolerance in IBS and utility of fructose-restricted diet. J Clin Gastroenterol. 2008;42(3):233–8. doi:10.1097/MCG.0b013e31802cbc2f.

    CAS  PubMed  Google Scholar 

  112. Nelis GF, Vermeeren MA, Jansen W. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology. 1990;99(4):1016–20.

    Article  CAS  PubMed  Google Scholar 

  113. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol. 2010;25:252–8.

    Article  PubMed  Google Scholar 

  114. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterol. 2014;146(1):67–75.

    Article  CAS  Google Scholar 

  115. Shepard SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc. 2006;106(10):1631–9.

    Article  Google Scholar 

  116. Yao CK, Biesiekierski J, Shepherd S, Gibson P. Dietary triggers for IB symptoms: the low FODMAP diet approach. Int Found Func Gastrointest Disord. 2014;251:1–4.

    Google Scholar 

  117. Azpiroz F, Malagelada JR. Abdominal bloating. Gastroenterol. 2005;129(3):1060–78.

    Article  Google Scholar 

  118. Erickson DR, Belchis DA, Dabbs DJ. Inflammatory cell types and clinical features of interstitial cystitis. J Urol. 1997;158(3 Pt 1):790–3.

    Article  CAS  PubMed  Google Scholar 

  119. Schmulson M, Chang L. Review article: the treatment of functional abdominal bloating and distension. Aliment Pharmacol Ther. 2011;33(10):1071–86.

    Article  CAS  PubMed  Google Scholar 

  120. Tuteja AK, Talley NJ, Joos SK, Tolman KG, Hickam DH. Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders epidemiology of bloating. Am J Gastroenterol. 2008;103:1241–8.

    Article  PubMed  Google Scholar 

  121. Seo AY, Kim N, Oh DH. Abdominal bloating: pathophysiology and treatment. J Neurogastroenterol Motil. 2013;19(4):433–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Leppert W. Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction. Drug Des Devel Ther. 2015;9:2215–31.

    Article  PubMed  PubMed Central  Google Scholar 

  123. Ho W, Siegel BMR. The relationship between obesity and functional gastrointestinal disorders: causation, association or neither? Gastroenterol Helpatol. 2008;4(8):562–78.

    Google Scholar 

  124. Theodorou V, Belgnaoui AA, Agostini S, Eutameme H. Effect of commensals and probiotics on visceral senstitivy and pain in irritable bowel syndrome. Gut Microbes. 2014;5(3):430–6.

    Article  PubMed  PubMed Central  Google Scholar 

  125. Tamma S, Shorter B, Toh KL, Moldwin R, Gordon B. Influence of polyunsaturated fatty acids on urologic inflammation. Int Urol Nephrol. 2015;47(11):1753–61. doi:10.1007/s11255-015-1108-8.

    Article  CAS  PubMed  Google Scholar 

  126. George AK, Sadek MA, Saluja SS, Fariello JY, Whitmore KE, Moldwin RM. The impact of neuropathic pain in the chronic pelvic pain population. J Urol. 2012;188(5):1783–7.

    Article  PubMed  Google Scholar 

  127. Omoigui S. The biochemical origin of pain: the origin of all pain is inflammation and the inflammatory response. Part 2 of 3- inflammatory profile of pain syndromes. Med Hypotheses. 2007;69(6):1169–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  128. Vas L, Pattanik M, Titarmore V. Treatment of interstitial cystitis/painful bladder syndrome as a neuropathic pain condition. Indian J Urol. 2014;30(3):350–3.

    Article  PubMed  PubMed Central  Google Scholar 

  129. Grover S, Srivastva A, Lee R, Tewari AK. Role of Inflammation in bladder function and interstitial cystitis. Ther Adv Urol. 2011;3(1):19–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  130. Liu H, Kuo H. Increased urine and serum nerve growth factor levels in IC suggest chronic inflammation is involved in the pathogenesis of disease. PLoS One. 2012;7(9):e44687.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  131. Logadottir Y, Delbro D, Lindholm C, Fall M, Pecker R. Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis. Int J Urol. 2014;21 Suppl 1:75–8.

    Article  CAS  PubMed  Google Scholar 

  132. Schrepf A, O’Donnell M, Luo Y, Bradley CS, Kreder K, Lutgendorf S. Inflammation and inflammatory control in interstitial cystitis/bladder pain syndrome: associations with painful symptoms. Pain. 2014;155(9):1755–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. Calder PC, Yaqoob P. Omega-3 polyunsaturated fatty acids and human health outcomes. Biofactors. 2009;35(3):266–72.

    Article  CAS  PubMed  Google Scholar 

  134. Calder P. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83(suppl):1505S–19.

    CAS  PubMed  Google Scholar 

  135. DeFilippis AP, Sperling LS. Understanding omega 3’s. Am Heart J. 2006;151:564–70.

    Article  CAS  PubMed  Google Scholar 

  136. Das UN. Beneficial effect (s) of n-3 fatty acids in cardiovascular diabetes: but why and how? Prostaglandins Leukot Essent Fatty Acids. 2000;63:351–62.

    Article  CAS  PubMed  Google Scholar 

  137. De Lorgeril M. Essential polyunsaturated fatty acid, inflammation. Atherosclerosis and cardiovascular diseases. Subcell Biochem. 2007;42:283–97.

    Article  PubMed  Google Scholar 

  138. Mori TA, Beilin LJ. Omega-3 fatty acids and inflammation. Atherosclerosis Rep. 2004;6:461–7.

    Article  Google Scholar 

  139. Nowlin SY, Hammer MJ, D’Eramo Melkus G. Diet, Inflammation, and glycemic control in type 2 diabetes: an integrative review of the literature. J Nutr Metabol. 2012;2012:1–21.

    Article  CAS  Google Scholar 

  140. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004;164(21):2335–43.

    Article  CAS  PubMed  Google Scholar 

  141. Sesti F, Capozzolo T, Pietropolli A, Collalti M, Bollea MR, Piccione E. Diet therapy: a new strategy for the management of chronic pelvic pain. Nutr Res Rev. 2011;24(1):31–8.

    Article  PubMed  Google Scholar 

  142. Parazzini F, Chiaffarino F, Surace M, Chatenoud L, Cipriani S, Chiantera V, et al. Selected food intake and risk of endometriosis. Hum Reprod. 2004;19(8):1755–9.

    Article  CAS  PubMed  Google Scholar 

  143. Ziaei S, Zakeri M, Kazemnejad A. A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhea. Br J Obstet Gynecol. 2005;112:466–9.

    Article  CAS  Google Scholar 

  144. Jiang Y, Wu S, Shu X, et al. Cruciferous vegetable intake is inversely correlated with circulating levels of proinflammatory markers in women. J Acad of Nutr and Diet. 2014;114(5):700–8. e2.

    Article  Google Scholar 

  145. Valtuena S, Pellegrini N, Franzini L, Bianchi MA, Ardigo D, Del Rio D, et al. Food selection based on total antioxidant capacity can modify antioxidant intake, systemic inflammation and liver function without altering markers of oxidative stress. Am J Clin Nutr. 2008;87(5):1290–7.

    CAS  PubMed  Google Scholar 

  146. Genkinger JM, Platz EA, Hoffman SC, Comatock GW, Helzlsouer KJ. Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland. Am J Epidemiol. 2004;160(12):1223–33.

    Article  PubMed  Google Scholar 

  147. Nguan C, Franciosi LG, Butterfield NN, Macleod BA, Jens M, Fenster HN. A prospective, double-blind, randomized cross-over study evaluating changes in urinary pH for relieving the symptoms of interstitial cystitis. BJU Int. 2005;95:91–4.

    Article  PubMed  Google Scholar 

  148. Lomar MCE. Review article: the aetiology, diagnosis, mechanisms and clinical evidence for food intolerance. Aliment Pharmacol Ther. 2015;41:262–75.

    Article  CAS  Google Scholar 

  149. Maurer Abbot J, Byrd-Bredbenner C. The state of the American diet. How can we cope? Top Clin Nutr. 2007;22(3):202–33.

    Article  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge LIU Post Nutrition Program graduates, Felicia DiFiore, Christine Hanley, and Stefania Mascioli, for their assistance with this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Barbara Shorter .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Shorter, B., Gordon, B. (2017). Diet Therapy in the Context of Chronic Pelvic Pain. In: Moldwin, R. (eds) Urological and Gynaecological Chronic Pelvic Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-48464-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-48464-8_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-48462-4

  • Online ISBN: 978-3-319-48464-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics